15 ML daratumumab-fihj 120 MG/ML / hyaluronidase-fihj 2000 UNT/ML Injection [Darzalex Faspro]
RxNorm concept 2375141, branded drug (sbd). Prescribable name: DARZALEX Faspro 1800 MG / 30,000 UNT in 15 mL Injection.
- RxCUI
- 2375141
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2375141 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
DARZALEX Faspro (daratumumab-hyaluronidase-fihj 1800 MG /30,000 UNT) per 15 ML Injection; DARZALEX Faspro 1800 MG / 30,000 UNT per 15 mL Injection
Related concepts
- daratumumab-fihj 120 MG/ML (SCDC, consists of)
- hyaluronidase-fihj 2000 UNT/ML (SCDC, consists of)
- daratumumab-fihj 120 MG/ML / hyaluronidase-fihj 2000 UNT/ML [Darzalex Faspro] (SBDC, consists of)
- Injection (DF, has dose form)
- Darzalex Faspro (BN, has ingredient)
- 15 ML daratumumab-fihj 120 MG/ML / hyaluronidase-fihj 2000 UNT/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2375141 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2375141 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2375141. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.